The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem ...

The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL).

The best speed test apps can help ensure you really are getting all of the data you pay your internet service provider (ISP) for each month. However, they can also indicate whether or not it’s ...

Despite research showing the benefits of circulating tumor DNA as an indicator of disease remission in B-cell lymphoma, ...

See a doctor who has experience with it. You’ll find dermatologists who have experience with cutaneous T-cell lymphoma at Find a Dermatologist. Click on "Filters". Select "Any condition" and choose ...

Immunohistochemistry (IHC) is a special test used by pathologists to detect specific molecules ... Sometimes immunohistochemistry is helpful not only to identify the particular kind of lymphoma but ...

The last step is a short wait for your results to arrive digitally. A DNA test allows you to learn more about your heritage, health, genetic conditions, family history and potential genetic ...

IDEXX will offer a new canine lymphoma test in the U.S. and Canada in late March. Shares of IDEXX Laboratories (IDXX) surged 10% to lead S&P 500 gainers Monday after the provider of veterinary ...

One possibility for this is that patients who have a blood test soon after surgery showing evidence of ctDNA have a higher risk to relapse and may benefit from additional therapies beyond standard ...

a diagnostic panel with early detection of lymphoma in canine patients. The new panel is an accessible blood test that can be added to the panels of sick pets and can be integrated into annual ...

But what also drives her goes well beyond the classroom. "When I was six, I was diagnosed with Stage 4 lymphoblastic lymphoma and that really shaped me as a person in a way that I was surrounded ...

Follicular lymphoma is a very diverse disease, and decisions to treat in the frontline are made based on histology, disease burden and patient symptoms. The general approach should be a ...